Semaglutide results at 8 weeks: what the evidence says

The decision you're actually facing at week 8

Most people land on this page because they're unsure whether to continue. The numbers on the scales aren't yet dramatic, side effects may have been uncomfortable, and a small voice is asking whether this is worth it. That's the decision worth examining — not whether semaglutide works in principle, but whether your specific eight-week picture is consistent with a treatment that's on track.

The honest answer is that eight weeks is still early. Wegovy's titration schedule starts at 0.25mg and steps up roughly every four weeks. By week eight, you're likely at 1mg, a quarter of the 2.4mg dose used in the published STEP 1 trial in the New England Journal of Medicine, which recorded around 15% average body-weight reduction at 68 weeks. The physiology hasn't had time to fully respond. Loss of a few kilograms at this stage is both common and appropriate. If you're seeing that, the treatment is doing what it should.

What should tip your thinking the other way: if side effects have been severe and unrelenting past week six, or if nothing at all has changed despite consistent use, those are conversations to have with your prescriber, not conclusions to draw alone.

What actually drives results in the first eight weeks

Semaglutide is a GLP-1 receptor agonist. It mimics a gut hormone that signals fullness to the brain, slows how quickly food leaves the stomach, and reduces appetite at the level of the hypothalamus. In the first weeks, the dominant effect most people notice is simply eating less without forcing it, portions feel satisfying sooner, cravings quiet down.

This appetite suppression is real and measurable even at lower doses. The NHS medicines page for semaglutide explains the mechanism in plain terms. But the scale response at eight weeks reflects low-dose physiology. The metabolic adaptations that produce larger losses (improved insulin sensitivity, sustained hormonal changes, reduced fat mass feeding back into further appetite regulation) take longer to establish. That's not a flaw in the medicine; it's how biological systems respond to incremental change.

One practical habit worth building now: weigh yourself at the same time each morning, before eating or drinking, and note it weekly rather than daily. Daily fluctuations of 1–2kg from water retention, digestion and hormonal cycles can look like stalls. A weekly average tells a clearer story and takes under a minute to log.

How 8-week progress compares across the treatment arc

Putting eight weeks in context helps. The STEP 1 trial data show that weight loss is gradual and cumulative across the full 68 weeks. Most participants were still in the titration phase at two months. The steeper part of the loss curve arrives once the maintenance dose of 2.4mg is reached and sustained, typically around weeks 16 to 20 for people who tolerate titration without extended pauses.

If you want a direct comparison of what earlier and later timepoints look like, our pages on results at six weeks and results at twelve weeks break down those windows in the same format. For a fuller picture of the treatment timeline, how long Wegovy takes to work covers the arc from first dose to full effect.

It's also worth knowing that the NICE appraisal of semaglutide recommends reviewing whether to continue at six months on the maintenance dose, not at eight weeks. Stopping early, before the dose is even established, is the most common reason people don't see the results the trial evidence supports. That isn't a reason to push through genuine clinical concerns; it is a reason not to quit based on impatience alone.

When to speak to someone, and what to do next

If your eight-week picture includes consistent nausea that's affecting your quality of life, very slow loss despite good adherence, or any new symptoms you're uncertain about, a prescriber conversation is the right move. For information on the Wegovy treatment itself (how it's dispensed, what clinical review involves and what ongoing support looks like) our treatment overview covers it. If cost is a factor in your thinking, the treatment pricing page sets out what one transparent fee includes.

For those still deciding whether to start, how long Wegovy treatment runs and how to access it through a regulated UK pharmacy are both useful reading. Our clinical team reviews every consultation personally. If you have a question that doesn't fit neatly into a page, our FAQs or the support team are there.

When you're ready to take the next step, check your eligibility with a free consultation, reviewed the same day by a GPhC-registered prescriber.